CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 323 enrolled
Drug / intervention
Acclarent Eustachian Tube Balloon Catheter (ETBC)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02087150
NCT02087150N/ACompleted
CompareCT.gov

A Randomized Clinical Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter (ELLIOTT)

Integra LifeSciences Corporation·interventional·Posted Mar 14, 2014·Updated Jul 12, 2024

In Brief

A clinical study evaluating Acclarent Eustachian Tube Balloon Catheter (ETBC) for Eustachian Tube Dysfunction. Completed, enrolled 323 participants across 21 sites.

Detailed Summary

The objective of this study is to determine whether Eustachian tube dilation in conjunction with medical management or medical management alone is effective for treating Eustachian tube dysfunction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEustachian Tube Dysfunction
CountriesUnited States
CollaboratorsAcclarent

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 14, 2014
Enrollment StartFeb 1, 2014
Primary CompletionDec 1, 2016
Study CompletionJan 12, 2017
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 12.3 years ago

Interventions

Acclarent Eustachian Tube Balloon Catheter (ETBC)device